Context Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CNTX annual revenue was $0.0, with N/A growth year-over-year.
CNTX revenue history
Current Revenue
$0.0
Current Earnings
-$26.7M
Current Profit Margin
0%
Be the first to know when CNTX announces revenue.
CNTX Revenue History By Year
CNTX Yearly Revenue
CNTX Revenue
CNTX Change
CNTX Revenue Growth
2024-12-31
$0.00
N/A
N/A
2023-12-31
$0.00
N/A
N/A
2022-12-31
$0.00
N/A
N/A
2021-12-31
$0.00
N/A
N/A
2020-12-31
$0.00
N/A
N/A
2019-12-31
$0.00
N/A
N/A
1 of 1
Context Therapeutics Revenue FAQ
What was CNTX's revenue last quarter?
Context Therapeutics (NASDAQ: CNTX) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Context Therapeutics's revenue was $0.00.
What was Context Therapeutics's revenue in 2024?
Context Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
How much does Context Therapeutics make in a day?
Based on Context Therapeutics annual revenue for the past five years, CNTX makes an average of $0.00 per day.
What was Context Therapeutics's annual revenue growth in the past year?
As of Q2 2025, Context Therapeutics's revenue has grown null year over year. Context Therapeutics's revenue in the past year totaled $0.00.
How much does Context Therapeutics make in a year?
Context Therapeutics's revenue by year for the past five years is:
Context Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
Context Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
Context Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
Context Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
Context Therapeutics's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.